Contracts › 75N93019F00131
75N93019F00131: 1800013I Battelle Memorial Institute; Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) Against Bsl-4 Pathogens in Nhps; to 2 Base Award; Biod Can 8470038; $616,957
Awarded to Battelle Memorial Institute by National Institutes of Health (NIH).
$11.5Mobligated
$20.6Mpotential value
31 May 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93019F00131 |
|---|---|
| Vehicle | 75N93018D00013 |
| Awardee | Battelle Memorial Institute |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541713 Research and Development in Nanotechnology |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | OH |
| Period of performance | 30 July 2019 to 31 May 2028 |
| Potential end | 31 May 2028 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 06 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541713 contracts · All expiring contracts · USASpending record